$MJ Why President Trump Will Leave Legal Marijuana Alone

New Post Public Reply Private Reply Replies (0) Message Board
mc67
691
$MJ Why President Trump Will Leave Legal Marijuana Alone https://shar.es/1RcjTe

Why President Trump Will Leave Legal Marijuana Alone

Protected By The Rohrabacher-Farr Amendment And Rising In Popularity

Posted by Reginald Reefer on Friday May 26, 2017


Personally, I hate talking about Trump. However, today we have to do so since Trump did say some pretty ‘aggressive’ things about cannabis and the cannabis industry.
 
 
This right after Congress essentially tied up Jeff Sessions’ hands in relation to prosecuting legal medical marijuana businesses in states that have legalized it. This comes under a rider that was introduced and signed by Trump known as the Rohrabacher-Farr Amendment. Meaning, it is the law right now.
 
 
What does the Rohrabacher-Farr Amendment imply?

While there are a few bills circulating the political arena that would grant full legalization of cannabis, it isn’t likely that it will pass any time soon. Thus, Congress-people use budgetary bills to slip in pro-cannabis policy as is the case of the Rohrabacher-Farr Amendment.
 
 
Essentially, this rider means that the DOJ and the DEA are barred from using federal funds to prosecute medical marijuana businesses in places that legalized it. In other words, federal laws against marijuana is still on the books, the DOJ just can’t use any money to enforce them.
 
 
As you can imagine, the cannabis industry touted this as a great victory, until Trump had to release a signing statement that read;
 
 
“I will treat this provision [the R-F Amendment] consistently with my constitutional responsibility to take care that the laws be faithfully executed,”
 
 
While this doesn’t mean he’s outright saying, “I’m going to ignore this”, it does leave wiggle room for him to do so if he chooses. After all, he is right in everything he said.
 
 
The only problem is that the President of the US doesn’t have power of the Federal Purse, that is the responsibility of Congress. So even if he goes full on “drug warrior” on legal cannabis, he still would have to take it to a Federal court and win. This seems to be a difficult task since the 9th district court upheld the validity of the rider.
 
 
Can Trump still push back?
 
 
Of course he can, however the question that we should be asking is, “will he?” Trump has a lot on his plate and to tackle cannabis, which is the fastest growing political issue in the US, going against the will of the people is ill-advised.
 
You see, for the last three presidential elections, cannabis has outdone all the candidates in terms of popularity. There are 28 states and the District of Columbia that have legal cannabis systems in place. The industry is generating billions of dollars each year and creating thousands of new jobs.
 
 
Can you imagine what would happen if Trump were to piss off the cannabis industry as a whole? You’d have nearly half of the entire population in the US rising up against it.
 
 
People are sick and tired of the war on drugs and for Trump to re-ignite it would be a massive political mistake. I would even argue that it could get him removed from the Presidency seeing that millions of people rely on it now.
 
 
Not only is legal cannabis reducing the spending on Medicaid, it’s helping curb an opioid epidemic as well as generating new income for states that have legalized.
 
 
Cannabis is a Subject that Embarks a lot!

You have to understand that cannabis isn’t about smoking weed only. It’s about healthcare, job creation, reduction of stress on the justice system, new revenue streams, human rights, discrimination against minorities and so much more.
 
 
The government wants you to believe that this subject is just about weed, however we all know that cannabis has intricately placed itself in the middle of many social issues. Even if you don’t smoke marijuana, it still affects you whether it’s legal or not.
 
 
Thus, cannabis is a very difficult topic to simply “uproot”, especially since we have already witnessed a failed attempt at prohibiting the substance. People now have the insight to see that the current approach of the government isn’t working.
 
 
Hell, in states that have legalized, teens aren’t consuming more. Traffic fatalities are dropping. Overdoses on Opioids are dropping. We’re seeing way more benefits than any potential risk that was sold to us over the years.
 
 
Then comes the medical aspect of cannabis. People getting treated with the plant from Seizure Disorders, cancer, IBS, autoimmune disorders, pain management, psychological issues and much more. If you assault cannabis, you assault all of these people and we know that within any great cause, martyrs are usually the elements that sway public opinion in favor of the cause.
 
 
So Trump goes and takes away medicine from a baby with 300 seizures a week, you can rest assured that that scenario is a political nightmare. You know how they say taking candy from a baby is bad…well, taking lifesaving medicine from infants is way worse. 

Trump will not do anything
 
 
I don’t think Trump will be dumb enough to tackle the cannabis industry. We have grown significantly over the past few years and nowadays cannabis is no longer a fringe topic. It’s starting to get center stage and the people of the World have spoken; We want it all and we want it now!
  (cont'd) ..click link for pics/graphs





Read More: https://investorshangout.com/post/view?id=457...z4iR9fRhM7
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading